|
Q3 FY2026
As of Jun 28, 2026
|
Q2 FY2026
As of Mar 29, 2026
|
Q1 FY2026
As of Dec 28, 2025
|
Q4 FY2025
As of Sep 28, 2025
|
Q3 FY2025
As of Jun 29, 2025
|
Q2 FY2025
As of Mar 30, 2025
|
Q1 FY2025
As of Dec 29, 2024
|
Q4 FY2024
As of Sep 29, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Oct 1, 2023
|
Q3 FY2023
As of Jul 2, 2023
|
Q2 FY2023
As of Apr 2, 2023
|
Q1 FY2023
As of Jan 1, 2023
|
Q4 FY2022
As of Oct 2, 2022
|
Q3 FY2022
As of Jul 3, 2022
|
Q2 FY2022
As of Apr 3, 2022
|
Q1 FY2022
As of Jan 2, 2022
|
Q4 FY2021
As of Oct 3, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Accounts Receivable, Net | ||||||||||||||||||||
| Inventory, Net | ||||||||||||||||||||
| Contract Asset | ||||||||||||||||||||
| Prepaid Expenses | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Property and Equipment, Net | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Deferred Tax Asset | ||||||||||||||||||||
| Intangibles, net | ||||||||||||||||||||
| Right-of-use Asset | ||||||||||||||||||||
| Security Deposits | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts Payable | ||||||||||||||||||||
| Credit Facility | ||||||||||||||||||||
| Operating Lease Liability | ||||||||||||||||||||
| Federal Income Taxes Payable | ||||||||||||||||||||
| Accrued Expenses | ||||||||||||||||||||
| Accrued Selling Expense | ||||||||||||||||||||
| Accrued Warranty Costs | ||||||||||||||||||||
| Contract Loss Reserves | ||||||||||||||||||||
| Customer Advance Deposits | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Credit Facility-Long Term | ||||||||||||||||||||
| Operating Lease Liability, net of current portion | ||||||||||||||||||||
| Fair Value of Contingent Liability | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Common Stock – ($0.001 par, 2,000,000,000 authorized, and issued and outstanding shares of 6,959,873 and 6,920,658 as of June 28, 2026 and September 28, 2025, respectively) | ||||||||||||||||||||
| Additional Paid in Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
